|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
CO-ADMINISTRATION IN PATIENTS WHO ARE RECEIVING HIGH DOSES OF THEOPHYLLINE MAY BE ASSOCIATED WITH AN INCREASE IN SERUM THEOPHYLLINE LEVELS AND POTENTIAL THEOPHYLLINE TOXICITY
|
CO-ADMINISTRATION IN PATIENTS WHO ARE RECEIVING HIGH DOSES OF THEOPHYLLINE MAY BE ASSOCIATED WITH AN INCREASE IN SERUM THEOPHYLLINE LEVELS AND POTENTIAL THEOPHYLLINE TOXICITY
|
CO-ADMINISTRATION IN PATIENTS WHO ARE RECEIVING HIGH DOSES OF THEOPHYLLINE MAY BE ASSOCIATED WITH AN INCREASE IN SERUM THEOPHYLLINE LEVELS AND POTENTIAL THEOPHYLLINE TOXICITY
|
CO-ADMINISTRATION IN PATIENTS WHO ARE RECEIVING HIGH DOSES OF THEOPHYLLINE MAY BE ASSOCIATED WITH AN INCREASE IN SERUM THEOPHYLLINE LEVELS AND POTENTIAL THEOPHYLLINE TOXICITY
|
CO-ADMINISTRATION IN PATIENTS WHO ARE RECEIVING HIGH DOSES OF THEOPHYLLINE MAY BE ASSOCIATED WITH AN INCREASE IN SERUM THEOPHYLLINE LEVELS AND POTENTIAL THEOPHYLLINE TOXICITY
|
THEOPHYLLIN POTENTIATES ITS METABOLISM , HENCE SERUM CONCENTRATION IS DECREASED
|
METHYLXANTHINES ARE NON-SPECIFIC ADENOSINE RECEPTOR ANTAGONISTS & MAY INTERFERE WITH THE VASODILATATION
|